LuIII parvovirus selectively and efficiently targets, replicates in, and kills human glioma cells.

LuIII parvovirus selectively and efficiently targets, replicates in, and kills human glioma cells.
复制标题

LuIII 细小病毒选择性且有效地靶向、复制并杀死人类神经胶质瘤细胞。

DOI:
10.1128/jvi.00227-12
复制
发表时间:
2012
影响因子:
5.4
通讯作者:
vandenPol,AnthonyN
vandenPol,AnthonyN
中科院分区:
医学2区
文献类型:
--
作者:
Paglino,JustinC;Ozduman,Koray;vandenPol,AnthonyN

文献摘要

参考文献

相似文献

Because productive infection by parvoviruses requires cell division and is enhanced by oncogenic transformation, some parvoviruses may have potential utility in killing cancer cells. To identify the parvovirus(es) with the optimal oncolytic effect against human glioblastomas, we screened 12 parvoviruses at a high multiplicity of infection (MOI). MVMi, MVMc, MVM-G17, tumor virus X (TVX), canine parvovirus (CPV), porcine parvovirus (PPV), rat parvovirus 1A (RPV1A), and H-3 were relatively ineffective. The four viruses with the greatest oncolytic activity, LuIII, H-1, MVMp, and MVM-G52, were tested for the ability, at a low MOI, to progressively infect the culture over time, causing cell death at a rate higher than that of cell proliferation. LuIII alone was effective in all five human glioblastomas tested. H-1 progressively infected only two of five; MVMp and MVM-G52 were ineffective in all five. To investigate the underlying mechanism of LuIII's phenotype, we used recombinant parvoviruses with the LuIII capsid replacing the MVMp capsid or with molecular alteration of the P4 promoter. The LuIII capsid enhanced efficient replication and oncolysis in MO59J gliomas cells; other gliomas tested required the entire LuIII genome to exhibit enhanced infection. LuIII selectively infected glioma cells over normal glial cellsin vitro. In mouse models, human glioblastoma xenografts were selectively infected by LuIII when administered intratumorally; LuIII reduced tumor growth by 75%. LuIII also had the capacity to selectively infect subcutaneous or intracranial gliomas after intravenous inoculation. Intravenous or intracranial LuIII caused no adverse effects. Intracranial LuIII caused no infection of mature mouse neurons or gliain vivobut showed a modest infection of developing neurons.
细小病毒的抗肿瘤活性。
DOI: --
发表时间: 1991
影响因子: 3.1
作者:
J. Rommelaere;J. Cornelis
通讯作者: J. Cornelis
小鼠微小病毒主要非结构核蛋白的单克隆抗体。
DOI: --
发表时间: 1991
期刊: Virology
影响因子: 3.7
作者:
Douglas E. Yeung;Grant W. Brown;Patrick Tam;Roland H. Russnak;Gary M. Wilson;Ian Clark;C. Astell
通讯作者: C. Astell
DOI: 10.1016/j.virol.2006.11.006
发表时间: 2007-04
期刊: Virology
影响因子: 3.7
作者:
J. Paglino;E. Burnett;P. Tattersall
通讯作者: J. Paglino;E. Burnett;P. Tattersall
DOI: 10.1007/bf01317833
发表时间: 2005
影响因子: 2.7
作者:
P. Arstila
通讯作者: P. Arstila
上游 CRE 参与小鼠启动子 P4 微小病毒的基础活性及其对 ras 转化细胞的刺激
DOI: 10.1128/jvi.69.9.5506-5515.1995
发表时间: 1995
影响因子: 5.4
作者:
M. Perros;L. Deleu;J. Vanacker;Z. Kherrouche;N. Spruyt;S. Faisst;J. Rommelaere
通讯作者: J. Rommelaere